:26 /" .

? GFR- :

, .

" .
) ( . .
:

BUN/

:
. )
( . .GFR-
:
5%
30% )( -
.80%- .
:

-azotemia .
-Uremia .
- 400-500" ) . (400
- 100-" .

.
) , ,( . ?

) (.

- )

120(.
- D

- - -

.
: 3:
-Pre-renal .

.
. -
. .
.Renal- acute GN .

. .(acute tubular necrosis (ATN

-Post-renal ) " (.

:
80% ARF- ATN-.

90% intrinsic renal- ) ATN -

(.
:Pre renal acute renal failure

3
:

-Effective volume depletion

. . .
:Volume depletion-
.
: , ,
: , DI ,
: , insensible losses-
:3rd spacing : )( ,-
)( , )( .
-Effective blood volume depletion
effective- :
, , .
- , ,
Hypercalcemia, Hepato-Renal syndrome, cyclosporine A:
) " .(ACEI, NSAID, ARB :
:
Myogenic stretch receptors

Angiotensin II

(Tubuloglomerular feedback (TGF

) EA" ' ' (,

AA ) TGF- (
GFR-.
:
. :
' -II ) PT-"

EA (.
- CD-

-ADH CD-" .

- )
(.
II .EA- .
.
.
ACE .
-?

- ) (
) (
- ) (.

-Fractional excretion of Na . -
.
FENa= UrineNa * volume / plasmaNa * GFR X 100= U/P [Na]/U/P [Cr] X 100
1%- - ) (.

1%- acute tubular necrosis -

) (.
?
70 .
GFR- .
.
:
-UNa < 10 meq/L .

-FENa <1% .

-Uosm > 500mosmol/Kg .

-Specific gravity > 1.02 .

) )1.008-1.009
Plasma BUN/Creatinine > 20
.
: , - .

hyaline casts- TAL Tamm horsphal

.
) (.
:

.1
.2
.3
.4
.5

) (:
-Acute tubular necrosis
Acute interstitial nephritis
Acute GN
) : (
.

Acute tubular necrosis

.1
) -( :
) , ,( , ; , , ,
) Ig ( . .
.1

ATN:

 pre renal ARF-

) .(acute tubular necrosis
.
? ?

. S3 : ,(PT (pars recta- TAL-
. 80-100-
50- .10-20
:
' .

NO- . TGF-
.
.
PT- : MD-
MD- GFR- TGF-
. " AA- PG
. GFR-.
:


. -
.
:
ATP

, =< .

: ,
. Tamm horsphal-
.TAL- .
GFR
.
, ATN-:

:
) initiation-( - " .
. .reperfusion injury
-Maintenance .
. .
.

 :
Differentiation

Proliferation

Migration

:
pre-renal-
- ) (ATN
) 20" ( . ) isosteuria
( , ) 10--
FE .)15 ) 1%- ( . , tamm
.horsphal .
pre-renal ATN-:
ATN

Pre-renal

<1%

>1%

FE Na

<20

>10

UNa

~USG 1.020< 1.01

~300

<500

>20< 10-15

U osmol
BUN/Creat

:ATN-
.
- .
.ATN-
) ,
( . )
( . . ,DIC- ,TTP ,
. .
pre-renal .ATN-
21
ATN .
ATN:
.2
:
- . .
) ( , ,.
- .
ATN " :

? .
) ( .
- . NO .
) (Tamm Horsphal-

 . ATN ,
.pre-renal
:
, - ) ).coca-cola

-CPK )

(.
, , -

.
- .

-FE Na <1% ) " (.

) (stick , .

) - (.

" .radio immunoassay

:
volume depletion . "
) ,tamm horsphal-
( . 300" ) (.
. ) fasioctomy
( .
" ) ( .
.
scavenger . ATN-
. ATN )
( . )(
. ATN .
ATN " :

) ( . , ,
) G6BD ( . .
ATN- ) tumor lysis syndrome

(-
) ( " )
( DT- )
.(acute uric acid nephropathy .Ca/P
.
:

) (
Uric Acid, P, K : ) (.
) (.
-Uua/Ucreat> 1 mg/mg .

- ) (:
-Allopurinol ."

).(urate oxidase

. .
ATN :

.ATN PT-
.
PT- . PT-
.ATN , Tamm horsphal-
) ATN( . ) (.
Multiple myeloma Cast nephtopathy ATN- .
:
Interstitial nephritis

TLS- .

ATN :
)
( . "
GFR- .
. .
: , , ,.
-Contrast media nephropathy

ATN . 24-48 ATN 3-5

5-7 . .
:
- GFR TGF
.1
:
- ,--,
.2

.3
ATN
.4
EF- .1%-
?
.
N acetyl cysteine " .SH
. .
ATN .
:

Volume depletion


) ( , ,
' .
.
)(NSAID
-
- .
ATN ) (:

PT-
. PT- .
) ( .
3 3 .
.
7-10 .
)( ." . .
.
, .
: .
:

- ) ( .NSAID

(.

ATN :NSAID -

.
) ( PG .GFR-
).(effective volume depletion
:
AA GFR- . .ATN-
) PG ( - .
NSAID ) (
) ,MCD - (.

.ACE
:
:
.
.ATN


) ( . .
.
.
ARF- 20% .50%
:
, )
.1
" : ,- ,(
)(
.2
.
.3
:ATN-
:

ATN :

-
.1
-
.2

-
.3

.4
- ,
.5
)( , , ' .
) (
.
.

.80%